Specific prebiotics modulate gut microbiota and immune activation in HAART-naive HIV-infected adults: Results of the "cOPA" pilot randomized trial

A. Gori, G. Rizzardini, B. Van'T Land, K. B. Amor, J. Van Schaik, C. Torti, T. Quirino, C. Tincati, A. Bandera, J. Knol, K. Benlhassan-Chahour, D. Trabattoni, D. Bray, A. Vriesema, G. Welling, J. Garssen, M. Clerici

Research output: Contribution to journalArticle

Abstract

Intestinal mucosal immune system is an early target for human immunodeficiency virus type 1 (HIV-1) infection, resulting in CD4 + T-cell depletion, deterioration of gut lining, and fecal microbiota composition. We evaluated the effects of a prebiotic oligosaccharide mixture in highly active antiretroviral therapy (HAART)-naive HIV-1-infected adults. In a pilot double-blind, randomized, placebo-controlled study, 57 HAART-naive HIV-1-infected patients received a unique oligosaccharide mixture (15 or 30 g short chain galactooligosaccharides/long chain fructooligosaccharides/pectin hydrolysate-derived acidic oligosaccharides (scGOS/lcFOS/pAOS) daily) or a placebo for 12 weeks. Microbiota composition improved significantly with increased bifidobacteria, decreased Clostridium coccoides/Eubacterium rectale cluster, and decreased pathogenic Clostridium lituseburense/Clostridium histolyticum group levels upon prebiotic supplementation. In addition, a reduction of soluble CD14 (sCD14), activated CD4 +/CD25 + T cells, and significantly increased natural killer (NK) cell activity when compared with control group were seen in the treatment group. The results of this pilot trial highly significantly show that dietary supplementation with a prebiotic oligosaccharide mixture results in improvement of the gut microbiota composition, reduction of sCD14, CD4 + T-cell activation (CD25), and improved NK cell activity in HAART-naive HIV-infected individuals.

Original languageEnglish
Pages (from-to)554-563
Number of pages10
JournalMucosal Immunology
Volume4
Issue number5
DOIs
Publication statusPublished - Sep 2011

ASJC Scopus subject areas

  • Immunology
  • Immunology and Allergy

Fingerprint Dive into the research topics of 'Specific prebiotics modulate gut microbiota and immune activation in HAART-naive HIV-infected adults: Results of the "cOPA" pilot randomized trial'. Together they form a unique fingerprint.

  • Cite this

    Gori, A., Rizzardini, G., Van'T Land, B., Amor, K. B., Van Schaik, J., Torti, C., Quirino, T., Tincati, C., Bandera, A., Knol, J., Benlhassan-Chahour, K., Trabattoni, D., Bray, D., Vriesema, A., Welling, G., Garssen, J., & Clerici, M. (2011). Specific prebiotics modulate gut microbiota and immune activation in HAART-naive HIV-infected adults: Results of the "cOPA" pilot randomized trial. Mucosal Immunology, 4(5), 554-563. https://doi.org/10.1038/mi.2011.15